| Catalog No. | HY415026 |
|---|
| Species reactivity | Human |
|---|
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| Host species | Human |
|---|
| Isotype | IgG |
|---|
| Clone ID | IGN523 |
|---|
| Biological activity |
IGN523 elicits strong ADCC activity in Ramos, KG-1 and OCI-AML-3 cells, with EC 50 s of 18.6 ng/mL, 73.8 ng/mL and 83.3 ng/mL, respectively, does not reduce ADCC activity in IGN523 cells [1]. IGN523 (2 ug/mL, 0.5-48 h) elicits Caspase-dependent apoptosis, increases lysosomal membrane permeability and decreases amino acid transport in Ramos, KG-1 and OCI-AML-3 cells [1]. Apoptosis Analysis [1] Cell Line: Ramos, KG-1 and OCI-AML-3 cells Concentration: 2 ug/mL Incubation Time: 48 h Result: Decreased cell viability in the presence of AbXL (10 ug/mL) (Ramos: 70% reduction; OCI-AML-3: 76% reduction; KG-1: 80% reduction), but not when used alone. Increased caspase-3 and caspase-7 activity (Ramos: 3.3-fold; OCI-AML-3: 7.5-fold and KG-1: 6.6-fold). . IGN523 (15 mg/kg, i.p., once a week, twice/three times) inhibits tumor growth in Ramos and Dau xenografts mice model [1]. IGN523 (15 mg/kg, i.p., once a week, twice/three times/four times) inhibits tumor growth in AML and primary NSCLC xenograft mice models [1]. |
| Expression system |
Mammalian cells |
| Clonality |
Monoclonal |
| Target |
SLC3A2, 4F2hc, Lymphocyte activation antigen 4F2 large subunit, CD98, 4F2 cell-surface antigen heavy chain, Solute carrier family 3 member 2, MDU1, 4F2 heavy chain antigen |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Accession |
P08195 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
|
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | IGN523 |
|---|
| Background | Amino acid transporter heavy chain SLC3A2 (CD98) is a ~57 kDa protein. Acts as a chaperone that facilitates biogenesis and trafficking of functional transporters heterodimers to the plasma membrane. Forms heterodimer with SLC7 family transporters (SLC7A5, SLC7A6, SLC7A7, SLC7A8, SLC7A10 and SLC7A11), a group of amino-acid antiporters. Heterodimers function as amino acids exchangers, the specificity of the substrate depending on the SLC7A subunit. Heterodimers SLC3A2/SLC7A6 or SLC3A2/SLC7A7 mediate the uptake of dibasic amino acids. Heterodimer SLC3A2/SLC7A11 functions as an antiporter by mediating the exchange of extracellular anionic L-cystine and intracellular L-glutamate across the cellular plasma membrane. 1. Rossier, G. et al. (1999) The Journal of biological chemistry 274, 34948-54. PMID: 105749702. Bröer, A. et al. (2000) The Biochemical journal 349 Pt 3, 787-95. PMID: 109031403. Yanagida, O. et al. (2001) Biochimica et biophysica acta 1514, 291-302. PMID: 115570287. Parker, JL. et al. (2021) Nature communications 12, 7147. PMID: 348802328. Mastroberardino, L. et al. (1998) Nature 395, 288-91. PMID: 97510589. Torrents, D. et al. (1998) The Journal of biological chemistry 273, 32437-45. PMID: 982997410. Pfeiffer, R. et al. (1999) The EMBO journal 18, 49-57. PMID: 9878049 |
|---|
| References |
1. Hayes GM, Chinn L, Cantor JM, Cairns B, Levashova Z, Tran H, Velilla T, Duey D, Lippincott J, Zachwieja J, Ginsberg MH, H van der Horst E. Antitumor activity of an anti-CD98 antibody. Int J Cancer. 2015 Aug 1;137(3):710-20. [HY415026] |
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
中文
English
한국어
日本語
Español
Français
Русский
